123 related articles for article (PubMed ID: 11248796)
21. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
[TBL] [Abstract][Full Text] [Related]
22. Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy.
Pike-Overzet K; de Ridder D; Weerkamp F; Baert MR; Verstegen MM; Brugman MH; Howe SJ; Reinders MJ; Thrasher AJ; Wagemaker G; van Dongen JJ; Staal FJ
Leukemia; 2007 Apr; 21(4):754-63. PubMed ID: 17268520
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal translocations and leukaemia: a role for LMO2 in T cell acute leukaemia, in transcription and in erythropoiesis.
Rabbitts TH; Axelson H; Forster A; Grutz G; Lavenir I; Larson R; Osada H; Valge-Archer V; Wadman I; Warren A
Leukemia; 1997 Apr; 11 Suppl 3():271-2. PubMed ID: 9209362
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade.
Bain G; Cravatt CB; Loomans C; Alberola-Ila J; Hedrick SM; Murre C
Nat Immunol; 2001 Feb; 2(2):165-71. PubMed ID: 11175815
[TBL] [Abstract][Full Text] [Related]
25. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
Barndt R; Dai MF; Zhuang Y
J Immunol; 1999 Sep; 163(6):3331-43. PubMed ID: 10477603
[TBL] [Abstract][Full Text] [Related]
26. Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors.
Yates PR; Atherton GT; Deed RW; Norton JD; Sharrocks AD
EMBO J; 1999 Feb; 18(4):968-76. PubMed ID: 10022839
[TBL] [Abstract][Full Text] [Related]
27. Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors.
Blom B; Heemskerk MH; Verschuren MC; van Dongen JJ; Stegmann AP; Bakker AQ; Couwenberg F; Res PC; Spits H
EMBO J; 1999 May; 18(10):2793-802. PubMed ID: 10329625
[TBL] [Abstract][Full Text] [Related]
28. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
Baer R
Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
[TBL] [Abstract][Full Text] [Related]
29. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract][Full Text] [Related]
30. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
[TBL] [Abstract][Full Text] [Related]
31. The stem cell leukaemia (SCL) gene: a critical regulator of haemopoietic and vascular development.
Barton LM; Göttgens B; Green AR
Int J Biochem Cell Biol; 1999 Oct; 31(10):1193-207. PubMed ID: 10582347
[No Abstract] [Full Text] [Related]
32. Identification of DeltaEF1 as a novel target that is negatively regulated by LMO2 in T-cell leukemia.
Sun W; Yang S; Shen W; Li H; Gao Y; Zhu TH
Eur J Haematol; 2010 Dec; 85(6):508-19. PubMed ID: 20731704
[TBL] [Abstract][Full Text] [Related]
33. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
Robb L; Begley CG
Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
[TBL] [Abstract][Full Text] [Related]
34. Induction of a diverse T cell receptor gamma/delta repertoire by the helix-loop-helix proteins E2A and HEB in nonlymphoid cells.
Ghosh JK; Romanow WJ; Murre C
J Exp Med; 2001 Mar; 193(6):769-76. PubMed ID: 11257142
[TBL] [Abstract][Full Text] [Related]
35. E2A and HEB activate the pre-TCR alpha promoter during immature T cell development.
Takeuchi A; Yamasaki S; Takase K; Nakatsu F; Arase H; Onodera M; Saito T
J Immunol; 2001 Aug; 167(4):2157-63. PubMed ID: 11490000
[TBL] [Abstract][Full Text] [Related]
36. E protein function in lymphocyte development.
Quong MW; Romanow WJ; Murre C
Annu Rev Immunol; 2002; 20():301-22. PubMed ID: 11861605
[TBL] [Abstract][Full Text] [Related]
37. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.
Ballerini P; Blaise A; Busson-Le Coniat M; Su XY; Zucman-Rossi J; Adam M; van den Akker J; Perot C; Pellegrino B; Landman-Parker J; Douay L; Berger R; Bernard OA
Blood; 2002 Aug; 100(3):991-7. PubMed ID: 12130513
[TBL] [Abstract][Full Text] [Related]
38. [Regulation of hematopoiesis by transcription factors].
Kurokawa M; Hirai H
Tanpakushitsu Kakusan Koso; 2000 Jun; 45(9 Suppl):1565-72. PubMed ID: 10879135
[No Abstract] [Full Text] [Related]
39. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3.
Rivera RR; Johns CP; Quan J; Johnson RS; Murre C
Immunity; 2000 Jan; 12(1):17-26. PubMed ID: 10661402
[TBL] [Abstract][Full Text] [Related]
40. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes.
Rabbitts TH
Genes Dev; 1998 Sep; 12(17):2651-7. PubMed ID: 9732263
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
